Focus Stocks
Amgen Bears Firmly in Control
Published on Friday, 27 August 2010 11:35 Written by TradersHuddle Staff
New York, August 27th (TradersHuddle.com) - Shares of Amgen Inc. (NASDAQ:AMGN) booked a new 52 week low by trading below $50.32, traders are definitely monitoring Amgen's price action to see if this move attracts further selling, or it this last push down sets a tradable bottom in the stock.
Amgen Inc. (NASDAQ:AMGN) develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The company concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
Amgen is currently trading 0.44% versus its previous trading session close, and it has calculated support and resistance at $50.71 and $56.14 respectively. Clearly with this action this range has been penetrated, and traders will be reviewing price action to establish a new tradable range
The overall market index S&P 500 is trading higher by 1.13% from its previous trading close, which means that Amgen stock is underperforming the overall market.
Related Articles
- NASDAQ 100 Mid-day Update: Lower Top Performers: VRTX, FSLR, GILD
- Amgen near Resistance
- Is Amgen Breaking Out?
- Trading Idea - Is Amgen close to Resistance?
- Amgen Higher Ahead of Earnings
- Amgen near Key Resistance Area
- Up/Downgrades ( COP, FST, CMA, PNRA, ARW, AVT, ALTH, ACOR, AMGN, FST )
- Is Amgen Breaking Out?
- Amgen - Shares Seeking Direction
- Amgen - 52 Week High
Related Partner Headlines
- Deutsche Bank: Xgeva Not Proceeding Well for Amgen - Benzinga
- Amgen to Discuss Application for New Use of XGEVA at FDA Oncologic Drugs Advisory Committee Meeting - Benzinga
- Dendreon Rockets 17% After Critical Reveiw For Amgen's Cancer Drug - Benzinga
- Piper Jaffray Postive on Amgen After FDA Releases Briefing Documents on Xgeva - Benzinga
- FDA Skeptical of Amgen Drug Ahead of Panel - TheStreet.com
- Amgen Reaches New 52-Week High (AMGN) - TheStreet.com
- Stock Market Story: Jan. 27 - TheStreet.com
- Stocks to Watch: P&G, Ford, Starbucks - TheStreet.com
- Amgen Acquires Micromet for $1.16 Billion - TheStreet.com
- Limitations of Beta-Weighted Delta Hedging - TheStreet.com
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Recent Trading Ideas
Latest Partner Headlines
-
Benzinga's Microcap Movers for Wednesday February 8, 2012 - Benzinga -
Five More Stocks ETFs Need More Of - Benzinga -
ETFs to Watch February 9, 2012 - Benzinga -
'Fast Money' Recap: Cisco's Back - TheStreet.com -
Benzinga's M&A Chatter for Wednesday February 8, 2012 - Benzinga -
Market Preview: Fearing the Inevitable Pullback - TheStreet.com -
Mike Khouw's OpenTable Inc Trade - Benzinga -
Fast Money Picks For February 9th - Benzinga
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,883.95 Trade time:4:02PM EST Value change:▲5.75 (0.04%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,349.96 Trade time:4:31PM EST Value change:▲2.91 (0.22%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,915.86 Trade time:5:16PM EST Value change:▲11.78 (0.41%)In The Wires
-
SYNC Accelerates into 2013 as Standard Equipment on New Ford Fusion and Flex -
Bacteria Detection Time Cut From Days to Minutes -
Pantone Announces Fashion Color Report Fall 2012 -
Analog Devices’ Webcast Addresses How To Select The Right Differential ADC Driver For Your Design: Part Two -
EpiCept to Raise $2 Million in Registered Direct Offering -
The Eco Picture Diary Global Contest Ceremony and Partnership Press Event held at the UNESCO Headquarters -
CIOsynergy Announces Presidio as Official Sponsor for directIT Chicago 2012 -
3D Systems Brings 3D Content-to-Print Products and Services to PD&M










